Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
VTYX - Ventyx Biosciences, Inc.
Market Cap 2.15B P/E - EPS this Y 34.50% Ern Qtrly Grth -
Income -171.3M Forward P/E -11.46 EPS next Y -2.80% 50D Avg Chg 5.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 6.00%
Dividend N/A Price/Book 5.76 EPS next 5Y - 52W High Chg -22.00%
Recommedations 2.10 Quick Ratio 13.25 Shares Outstanding 70.67M 52W Low Chg 143.00%
Insider Own 3.31% ROA -35.29% Shares Float 49.68M Beta 0.37
Inst Own 91.55% ROE -56.29% Shares Shorted/Prior 8.60M/9.34M Price 36.68
Gross Margin - Profit Margin - Avg. Volume 725,169 Target Price 10.00
Oper. Margin - Earnings Date Nov 4 Volume 316,151 Change -1.37%
Healthcare | Biotechnology | United States
About Ventyx Biosciences, Inc.

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. The company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease. It is also developing VTX002, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in San Diego, California.

Ventyx Biosciences, Inc. News
11/17/24 Ventyx Biosciences, Inc.'s (NASDAQ:VTYX) latest 15% decline adds to one-year losses, institutional investors may consider drastic measures
11/12/24 Ventyx Biosciences Reports Q3 Financial Results and Pipeline Progress
11/12/24 Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
11/07/24 Ventyx Biosciences Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate Progress
10/29/24 These 2 ‘Strong Buy’ Penny Stocks Could Rally Over 500%, Say Analysts
10/15/24 Ventyx Biosciences Presents New 52-Week Results from the Phase 2 Trial of VTX002 (Tamuzimod) in Ulcerative Colitis at UEG Week 2024
09/24/24 VTYX Stock Rises on Strategic Equity Investment Deal With SNY
12:54 PM Sanofi gains exclusivity rights to Ventyx’s CNS-penetrant drug in $27m deal
07:00 AM Ventyx Biosciences Announces $27 Million Strategic Investment from Sanofi
09/06/24 Ventyx Biosciences Announces Initiation of Dosing in a Phase 2a Trial of VTX3232 in Patients with Early Parkinson’s Disease
08/30/24 Ventyx Biosciences Announces Departure of Chief Financial Officer
08/30/24 Novo builds heart failure case for semaglutide; Ventyx CFO departs
08/28/24 Ventyx Biosciences to Participate in Two Upcoming Investor Conferences
08/08/24 Ventyx Biosciences Reports Second Quarter 2024 Financial Results and Highlights Recent Corporate Progress
07/30/24 Ventyx scraps TYK2 inhibitor after Phase II Crohn’s defeat
07/29/24 Ventyx Biosciences Announces Results from the Phase 2 Trial of VTX958 in Participants with Moderately to Severely Active Crohn’s Disease
07/29/24 Ventyx’s TYK2 drug suffers second setback
07/06/24 Is Ventyx Biosciences (NASDAQ:VTYX) In A Good Position To Invest In Growth?
06/05/24 Ventyx Biosciences Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory Markers
05/16/24 Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer
VTYX Chatroom

User Image Dr_Monkeybreath Posted - 16 hours ago

$VTYX reminds me of $PULM BEFORE its big move up. ⏳📈💰💰💰

User Image Southski Posted - 17 hours ago

$VTYX

User Image iaconi Posted - 1 day ago

$VTYX Just bought more!!

User Image AmericaIsBack Posted - 1 day ago

$VTYX guess ill come back

User Image PenkeTrading Posted - 2 days ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Ventyx Biosciences Inc. Is that bullish or bearish? $VTYX #RsiOversold #NASDAQ

User Image Dr_Monkeybreath Posted - 4 days ago

$VTYX will $PULM very soon.🔮

User Image Dr_Monkeybreath Posted - 4 days ago

$VTYX 🍽️

User Image Jollygoodstonks Posted - 1 week ago

$VTYX going to low to high 1.8's. If we don't hold, 1.6. Don't go heavy just yet.

User Image iaconi Posted - 1 week ago

$VTYX Good price for entry!!

User Image cta7978 Posted - 1 week ago

$VTYX No Parkinsons data until H1-2025? When is Nodthera's data due?

User Image viking1111 Posted - 1 week ago

$VTYX added some 2.04's.

User Image sumon89 Posted - 1 week ago

$VTYX do something!!

User Image Joe_088 Posted - 1 week ago

$VTYX $VIGL $ALT 💎

User Image Southski Posted - 1 week ago

$VTYX

User Image Big_Dzick Posted - 2 weeks ago

$VTYX good dip here. Load and hold

User Image Southski Posted - 2 weeks ago

$VTYX About to GAP UP!!

User Image viking1111 Posted - 2 weeks ago

$VTYX the 2nd largest shareholder here listed on nasdaq.com inst holder list is citadel. They have way over 5 mil shares. They short an awful lot of penny stocks. They may be what is holding this up. Sooner or later this should start back up. Not sure when though.

User Image Joe_088 Posted - 2 weeks ago

$VKTX $VTYX 💎

User Image Stocksrockman Posted - 2 weeks ago

$SRM ✔️ It's going up a lot more ✔️ Buyers will come all at once ✔️ Fomo is real here ✔️ Low float $WBUY uptrend $VTYX strong watch $BZFD waking up $DATS I called at $1.17

User Image viking1111 Posted - 3 weeks ago

$VTYX this runs up or down on its own, not following the mkt or even the bio sector. Same thing with elev another one I bought hoping for a bounce. Just have to wait until the insts moving this down cover and send it back up.

User Image viking1111 Posted - 10/30/24

$VTYX more low vol back testing. At the moment chart still appears intact.

User Image Handstiedbull Posted - 10/30/24

$VTYX same ole dog

User Image incom101 Posted - 10/29/24

$RGLS $VTYX that's what got me to DD it.

User Image Southski Posted - 10/29/24

$VTYX

User Image TheSleeeve Posted - 10/28/24

$VTYX Almost a year later and right back to where it started.....Let's do it again. Looks like I'm the OG around here. Congrats longs.

User Image Joe_088 Posted - 10/28/24

$VTYX long 💎

User Image TipRanks Posted - 10/28/24

These 2 ‘Strong Buy’ Penny Stocks Could Rally Over 500%, Say Analysts https://tipranks.com/news/article/these-2-strong-buy-penny-stocks-could-rally-over-500-say-analysts $RGLS $VTYX

User Image viking1111 Posted - 10/28/24

$VTYX penny bios have been hot lately, let's join them.

User Image Southski Posted - 10/24/24

$VTYX Start MM'ing its way to the $2.50 OPEX

User Image viking1111 Posted - 1 month ago

$VTYX was hoping this was just going to keep heading up but it pulled back enough yesterday that I sold my 2.05's, took the profit and will try again when it settles at whatever bottom is this time around.

Analyst Ratings
HC Wainwright & Co. Neutral Sep 23, 24
Wells Fargo Overweight Aug 12, 24
Canaccord Genuity Buy Aug 12, 24
HC Wainwright & Co. Neutral Jul 30, 24
HC Wainwright & Co. Neutral Jun 13, 24
Oppenheimer Outperform Jun 6, 24
HC Wainwright & Co. Neutral Jun 6, 24
Canaccord Genuity Buy Mar 13, 24
Wells Fargo Overweight Mar 12, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Nuss John Chief Scientific Off.. Chief Scientific Officer Dec 20 Sell 2.1179 17,628 37,334 262,118 12/21/23
Krueger Christopher W Chief Business Offic.. Chief Business Officer Dec 20 Sell 2.1179 5,293 11,210 282,119 12/21/23
Mohan Raju CEO and President CEO and President Dec 20 Sell 2.1179 58,860 124,660 1,570,719 12/21/23
Mohan Raju CEO and President CEO and President Dec 17 Option 0.00 116,668 1,629,579 12/19/23
Nuss John Chief Scientific Off.. Chief Scientific Officer Dec 17 Option 0.00 34,931 279,746 12/19/23
Krueger Christopher W Chief Business Offic.. Chief Business Officer Dec 17 Option 0.00 10,479 287,412 12/19/23
NSV Partners III LP 10% Owner 10% Owner Oct 09 Sell 30.0264 49,152 1,475,858 8,439,635 10/11/23
Mohan Raju Chief Executive Offi.. Chief Executive Officer Oct 05 Sell 29.11 30,000 873,300 1,512,911 10/06/23
Mohan Raju Chief Executive Offi.. Chief Executive Officer Oct 05 Option 8.04 30,000 241,200 1,542,911 10/06/23
Krueger Christopher W Chief Business Offic.. Chief Business Officer Oct 03 Sell 30.31 15,000 454,650 276,548 10/04/23
Krueger Christopher W Chief Business Offic.. Chief Business Officer Oct 03 Option 8.04 15,000 120,600 291,548 10/04/23
Nuss John Chief Scientific Off.. Chief Scientific Officer Oct 03 Option 3.93 10,000 39,300 254,815 10/04/23
Nuss John Chief Scientific Off.. Chief Scientific Officer Oct 03 Sell 30.33 10,000 303,300 244,815 10/04/23
Subramaniam Somu Director Director Sep 18 Sell 37.8123 56,665 2,142,634 8,488,787 09/20/23
NSV Partners III LP 10% Owner 10% Owner Sep 18 Sell 37.8123 56,665 2,142,634 8,488,787 09/20/23
Sandborn William J. See Remarks See Remarks Aug 31 Sell 33.64 11,900 400,316 48,389 09/01/23
Sandborn William J. See Remarks See Remarks Aug 31 Option 14.85 11,900 176,715 60,289 09/01/23
Sandborn William J. See Remarks See Remarks Aug 08 Sell 32.9 3,494 114,953 24,194 08/08/23
Mohan Raju Chief Executive Offi.. Chief Executive Officer Aug 07 Sell 34.1 30,000 1,023,000 1,512,911 08/08/23
Mohan Raju Chief Executive Offi.. Chief Executive Officer Aug 07 Option 8.04 30,000 241,200 1,542,911 08/08/23
Nuss John Chief Scientific Off.. Chief Scientific Officer Aug 03 Sell 35.74 10,000 357,400 244,815 08/04/23
Nuss John Chief Scientific Off.. Chief Scientific Officer Aug 03 Option 0.2 10,000 2,000 254,815 08/04/23
Krueger Christopher W Chief Business Offic.. Chief Business Officer Aug 03 Sell 35.73 15,000 535,950 276,548 08/04/23
Krueger Christopher W Chief Business Offic.. Chief Business Officer Aug 03 Option 8.04 15,000 120,600 291,548 08/04/23
Subramaniam Somu Director Director Jul 28 Sell 37.56 11,414 428,710 8,545,452 08/01/23
NSV Partners III LP 10% Owner 10% Owner Jul 28 Sell 37.56 11,414 428,710 8,545,452 08/01/23
Auster Martin Chief Financial Offi.. Chief Financial Officer Jul 25 Sell 35.54 28,000 995,120 47,649 07/26/23
Auster Martin Chief Financial Offi.. Chief Financial Officer Jul 25 Option 3.45 28,000 96,600 75,649 07/26/23
NSV Partners III LP Director Director Jul 07 Sell 35.91 100,000 3,591,000 9,552,965 07/19/23
Subramaniam Somu Director Director Jul 07 Sell 35.91 100,000 3,591,000 9,552,965 07/19/23
NSV Partners III LP Director Director Jul 11 Sell 37.58 31,921 1,199,591 8,556,866 07/13/23
Subramaniam Somu Director Director Jul 11 Sell 37.58 31,921 1,199,591 8,556,866 07/13/23
NSV Partners III LP 10% Owner 10% Owner Jul 03 Sell 37.74 134,080 5,060,179 9,652,965 07/06/23
Subramaniam Somu Director Director Jul 03 Sell 37.74 134,080 5,060,179 9,652,965 07/06/23
Mohan Raju Chief Executive Offi.. Chief Executive Officer Jul 05 Sell 39.14 30,000 1,174,200 1,512,911 07/05/23
Mohan Raju Chief Executive Offi.. Chief Executive Officer Jul 05 Option 8.04 29,785 239,471 1,542,911 07/05/23
Nuss John Chief Scientific Off.. Chief Scientific Officer Jul 03 Sell 36.86 20,000 737,200 244,815 07/05/23
Nuss John Chief Scientific Off.. Chief Scientific Officer Jul 03 Option 0.2 20,000 4,000 264,815 07/05/23
Krueger Christopher W Chief Business Offic.. Chief Business Officer Jul 03 Sell 36.75 15,000 551,250 276,548 07/05/23
Krueger Christopher W Chief Business Offic.. Chief Business Officer Jul 03 Option 4.12 15,000 61,800 291,548 07/05/23
Sandborn William J. See Remarks See Remarks Jul 03 Sell 40 15,387 615,480 27,688 07/05/23
Sandborn William J. See Remarks See Remarks Jul 03 Option 14.85 11,900 176,715 60,289 07/05/23
Sandborn William J. See Remarks See Remarks Jun 23 Sell 32.47 10,790 350,351 48,389 06/27/23
Sandborn William J. See Remarks See Remarks Jun 23 Option 0.2 10,790 2,158 59,179 06/27/23
Sandborn William J. See Remarks See Remarks Jun 15 Sell 34.31 3,487 119,639 31,175 06/16/23
Subramaniam Somu Director Director Jun 14 Sell 35.0757 50,000 1,753,785 9,787,045 06/16/23
NSV Partners III LP 10% Owner 10% Owner Jun 14 Sell 35.0757 50,000 1,753,785 9,787,045 06/16/23
Subramaniam Somu Director Director Jun 06 Sell 35.53 40,000 1,421,200 9,837,045 06/08/23
NSV Partners III LP 10% Owner 10% Owner Jun 06 Sell 35.53 40,000 1,421,200 9,837,045 06/08/23
Nuss John Chief Scientific Off.. Chief Scientific Officer Jun 05 Sell 34.46 10,000 344,600 244,815 06/07/23